The Wnt pathway in a normal and in a tumour cell HD

The metastatic thrombus HD

Vicious cycle in the generation of osteoclastic bone metastases in mammary cancer HD

Apoptosis HD

Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia HD

Communication of tumour cells with the microenvironment HD

Effects of proteinases with metalloproteinase domains (MMPs, ADAMs) on tumour progression HD

The PI3K/AKT signalling pathway HD

Molecular action of p53 in carcinogenesis HD

The MAP-Kinase (MAPK) signalling pathway HD

Protein kinase C HD

The tumour suppressor protein PTEN HD

Oncogenic activation receptor tyrosine kinases HD

Clonal evolution of tumours HD

Antibody therapy

Hypoxia Inducible Factors (HIFs), Part 3: Effects of Hypoxia Inducible Factors (HIFs)

Hypoxia Inducible Factors (HIFs), Part 2: Regulation of HIF under normoxic and hypoxic conditions

Hypoxia Inducible Factors (HIFs), Part 1: Tumor hypoxia

NF-κB pathways, Part 3: Activation of the NF-κB pathway in malignant disease

NF-κB pathways, Part 2: Alternative NF-κB pathway

NF-κB pathways, Part 1: The canonical pathway of NF-κB activation

Notch signaling

The hedgehog signaling pathway – Part 3

The hedgehog signaling pathway – Part 2

The hedgehog signaling pathway – Part 1: Normal situation

The JAK/STAT pathway

TGF-beta signaling

Activation of mTORC1 in hamartoma syndromes and spontaneous tumors

BCR-ABL1 and the Philadelphia chromosome - Part 4: Therapy of tumors with BCR-ABL1 fusion proteins

BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein

BCR-ABL1 and the Philadelphia chromosome - Part 2: The Philadelphia chromosome

BCR-ABL1 and the Philadelphia chromosome - Part 1: Normal and aberrant karyograms

The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 02

The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors. 01

The EGF receptor tyrosine protein kinases

General aspects of signal transduction

The cell cycle - Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

The cell cycle, Part 1: Phases and checkpoints

Oncogenic activation receptor tyrosine kinases

Protein kinase C

The MAP-Kinase (MAPK) signalling pathway

Vicious cycle in the generation of osteoclastic bone metastases in mammary cancer

The metastatic thrombus

Molecular action of p53 in carcinogenesis

Apoptosis

The Wnt pathway in a normal and in a tumour cell

Communication of tumour cells with the microenvironment

Effects of proteinases with metalloproteinase domains (MMPs, ADAMs) on tumour progression

The PI3K/AKT signalling pathway

Clonal evolution of tumours

Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

The tumour suppressor protein PTEN